Citation: N. Bodor et P. Buchwald, Drug targeting by retrometabolic design: Soft drugs and chemical delivery systems (Reprinted from Drug Targeting Technology: Physical - Chemical - Biological Methods - Drugs and the Pharmaceutical Sciences, vol 115, pg 163-187, 2001), J RECEPT SI, 21(2-3), 2001, pp. 287-310
Citation: N. Bodor et al., A tryptamine analog with high affinity to the heart tissues is a potentialantiarrhythmic agent, J PHARM PHA, 53(6), 2001, pp. 889-894
Citation: N. Bodor et P. Buchwald, Drug targeting by retrometabolic design - Soft drugs and chemical deliverysystems, DRUG PHARM, 115, 2001, pp. 163-187
Authors:
Yoon, SH
Wu, JX
Wu, WM
Prokai, L
Bodor, N
Citation: Sh. Yoon et al., Brain-targeted chemical delivery of [Leu(2), Pip(3)]-TRH: Synthesis and biological evaluation, BIO MED CH, 8(5), 2000, pp. 1059-1063
Citation: N. Bodor et al., Effect of cyclodextrins on the solubility and stability of a novel soft corti-costeroid, loteprednol etabonate, PHARMAZIE, 55(3), 2000, pp. 206-209
Citation: P. Buchwald et N. Bodor, Structure-based estimation of enzymatic hydrolysis rates and its application in computer-aided retrometabolic drug design, PHARMAZIE, 55(3), 2000, pp. 210-217
Citation: N. Bodor et P. Buchwald, Extended covalent solid forms of carbon dioxide with carbon-oxygen single bonds, CHEM P LETT, 319(5-6), 2000, pp. 645-649
Citation: Rj. Little et al., Soft drugs based on hydrocortisone: The inactive metabolite approach and its application to steroidal antiinflammatory agents, PHARM RES, 16(6), 1999, pp. 961-967
Citation: N. Bodor et P. Buchwald, Recent advances in the brain targeting of neuropharmaceuticals by chemicaldelivery systems, ADV DRUG DE, 36(2-3), 1999, pp. 229-254
Citation: Lf. Buris et al., Loteprednol etabonate, a new soft steroid is effective in a rabbit acute experimental model for arthritis, PHARMAZIE, 54(1), 1999, pp. 58-61
Citation: P. Buchwald et N. Bodor, Quantitative structure-metabolism relationships: Steric and nonsteric effects in the enzymatic hydrolysis of noncongener carboxylic esters, J MED CHEM, 42(25), 1999, pp. 5160-5168
Authors:
Prokai, L
Prokai-Tatrai, K
Ouyang, X
Kim, HS
Wu, WM
Zharikova, A
Bodor, N
Citation: L. Prokai et al., Metabolism-based brain-targeting system for a thyrotropin-releasing hormone analogue, J MED CHEM, 42(22), 1999, pp. 4563-4571